SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-09-000234
Filing Date
2009-08-06
Accepted
2009-08-06 08:54:22
Documents
9
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 561039
3 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 6546
4 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 6583
5 906 CERTIFICATE exh32.htm EX-32 2934
6 10-Q form10q.pdf 10-Q 472610
7 CEO 302 CERTIFICATE exhibit31-1.pdf EX-31.1 77573
8 CFO 302 CERTIFICATE exhibit31-2.pdf EX-31.2 77865
9 906 CERTIFICATE exhibit32.pdf EX-32 75208
10 LOGO newlogo.jpg GRAPHIC 111746
  Complete submission text file 0001136261-09-000234.txt   1702178
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 09990067
SIC: 2836 Biological Products, (No Diagnostic Substances)